EICHORCondition: Refractory or Unexplained Chronic Cough · Sponsor: Nocion Therapeutics
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalation Powder (NOC-110) once daily in adults with refractory or unexplained chronic cough.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| G & L Research, LLC | Foley, Alabama, United States | — |
| Medical Research of Arizona | Scottsdale, Arizona, United States | — |
| AMR Phoenix | Tempe, Arizona, United States | — |
| Little Rock Allergy & Asthma, P.A. Clinical Research Center | Little Rock, Arkansas, United States | — |
| So Cal Clinical Research | Huntington Beach, California, United States | — |
| Allergy and Asthma Associates of Southern California dba Southern California Research | Laguna Niguel, California, United States | — |
| Paradigm Clinical Research Centers, LLC - Modesto | Modesto, California, United States | — |
| NewportNativeMD,Inc | Newport Beach, California, United States | — |
| Center for Clinical Trials, LLC | Paramount, California, United States | — |
| Paradigm Clinical Research Centers, LLC | Redding, California, United States | — |
| DaVinci Research LLC. | Roseville, California, United States | — |
| Allergy & Asthma Associates of Santa Clara Valley | San Jose, California, United States | — |
+ 94 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06504446